Archive for January 2022

The business line, which Eastern inherited from Century Bank in their merger last year, has about $500 million in deposits and brings in a few million dollars annually in fee income. Read More

The Possible Zone, an educational nonprofit formerly in Cambridge, increasingly found it needed to be closer to many of the students it serves. So it’s moving from Kendall Square to Jackson Square, with new features the old location didn’t have. Read More

Form D Friday is a Boston Business Journal feature highlighting regulatory filings from Boston-area companies raising capital for new projects or expanding their businesses. Read More

Good morning, Boston. Here are the five things you need to know to start your busy workday, plus penny stocks, the first country club, a bracket challenge you don’t want to miss — and spying crabs. Read More

The long-proposed plan for Dorchester’s waterfront includes redevelopment of three existing buildings and the construction of two more to create 120 residential units, plus office space, retail and a 22,300-square-foot boathouse. Read More

CEO Amitai Ratzon said Pentera chose the Greater Boston area as headquarters for its North American operations due to "the large and diverse cyber security workforce located in the immediate area." Read More

Panelists said that despite the lingering challenges from the pandemic, inflation and the labor market, the area’s educated workforce and pent-up demand for shopping and travel will help speed recovery. Read More

Inno is bringing the innovation, tech and startup community together for some healthy competition…bracket-style! Read More

Few Massachusetts-based banks have made an initial stock offering in recent years, but 2022 can already claim one such offering. Read More

Cancer-focused precision medicine startup Scorpion Therapeutics, founded by serial entrepreneur Gary Glick and now headed up by GlaxoSmithKline plc veteran Axel Hoos, has made its next major move: signing a collaboration agreement worth up to $1.6 billion with the pharmaceutical giant AstraZeneca plc. Read More